Abnormal uterine bleeding is one of the most common problems in pre-menopausal women. Traditional Iranian Medicine has given numerous reasons for this problem. Some of these problems are focused upon the rheological changes that show up in the blood. Food recommendations are one of the first therapeutic measures in Traditional Iranian Medicine and determination of the type of patient's diet is an integral part of the therapeutic protocols of this medicine. This article intends to review the books of Traditional Iranian Medicine in addition to the nutritional recommendations of this science in abnormal uterine bleeding and explain their effect on changes in blood rheology. For this purpose, the texts of Iranian Medicine related to different ages were searched and dietary recommendations in abnormal uterine bleeding were extracted. From this point of view, some changes in the quality or quantity of blood, according to the science of fluid mechanics, increases fluidity of blood. The recommended diets in Traditional Iranian Medicine to correct these changes will help control and cure this problem.

Objectives: Heavy Menstrual Bleeding (HMB) is the most important problems of Uterine Leiomyoma (UL). This study aimed to assess the effect of the extract of the Capsella bursa-pastoris (CBP) on the control of HMB and quality of life in patients with uterine leiomyoma. Design: In a double-blind randomized, clinical trial 54 women with uterine leiomyoma were randomly assigned to the intervention/control groups by block randomization. Setting: Gynecology outpatient clinics. Intervention: The intervention group received 350 mg of alcoholic extract of Capsella bursa-pastoris and the control group received placebo twice daily for three months. Main Outcome Measures: Amount of bleeding by Pictorial blood loss assessment chart (PBAC), quality of life by menstrual quality of life questionnaires (MQ) and bleeding duration by calendar were evaluated. Results: The mean of PBAC decreased from 464.00± 283.61 at baseline to 323.82±207.66 in the intervention group and decreased from 445.92±362.64 to 214.36±137.68 in control group in the third month. The improvement trend was significant in the two groups, but there was no significant difference between groups. The mean of bleeding duration and menstrual quality of life showed improvement in patients of two groups without significant difference between the two groups. Conclusion: Despite the effectiveness of CBP in the intervention group in decreasing of PBAC score and menstrual bleeding duration and improvement of menstrual quality of life in patients who suffered from UL, it did not show a significant effect compared to the control group. Future studies with a larger sample size in one specific type of UL suggested.

No abstract